Aging of the Neutrophil Phenotype; Differences between a Healthy Young and Healthy Geriatric Population, Which Neutrophil is the Fittest?

Aging of the Neutrophil Phenotype; Differences between a Healthy Young and Healthy Geriatric Population, Which Neutrophil is the Fittest? - Fit Neutrophil study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON53554

Enrollment

Registered

2023-05-12

Start date

2023-09-08

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

immunologie aging immunesystem

Interventions

None listed

Eligibility

Age

65 Years to 99 Years

Inclusion criteria

Inclusion criteria: age 70 years and older

Exclusion criteria

Exclusion criteria: - Chronic immunocompromised status -Admitted to the hospital -Acute disease requiring treatment or medication

Design outcomes

Primary

Measure	Time frame
The main study parameter is the difference in neutrophil phenotype between a healthy geriatric and healthy young population.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results